Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Addressing Hypertension Care in Africa Program
NCT06986590 · View on ClinicalTrials.gov ↗
Study Summary
The ADHINCRA Program is a bundle of multilevel evidence-based interventions that address multiple predictors of controlled hypertension, including patient-, provider-, and health system-level factors. The successful implementation of the ADHINCRA program will provide a rigorous and scalable model for improving hypertension control in Africa, which would ultimately reduce the risk of cardiovascular disease, stroke and kidney disease.
Conditions Studied
Interventions
- BEHAVIORAL ADHINCRA Program
Study Locations (17)
Ondo State
- Akure South Hospital — Akure
- Akoko North East — Ondo
- Akoko North West — Ondo
- Akoko South East — Ondo
- Akoko South West — Ondo
- Owo General Hospital — Owo
Ashanti Region
- Dominase SDA Hospital — Bekwai
- Kumasi South Hospital — Kumasi
- Manhyia Government Hospital — Kumasi
- Tafo Government Hospital — Tafo
Bono
- Berekum Holy Family Hospital — Berekum
- St. John of God Catholic Hospital — Duayaw Nkwanta
Northern Region
- Northern Regional Hospital — Tamale
- Tamale Teaching Hospital — Tamale
Volta Region
- Ho Municipal Hospital — Ho
- South Tongu District Hospital — Sogakope
Maryland
- Johns Hopkins University — Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2026-01-09 |
| Est. Completion | 2028-09 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06986590
The ClinicalTrials.gov registry entry for NCT06986590 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,517 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention — of which ADHINCRA Program is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT06986590 reports 17 study locations spanning 6 distinct geographic areas — top geographies include Ondo State, Ashanti Region, Bono. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT06986590 about?
NCT06986590 is a clinical study titled "Addressing Hypertension Care in Africa Program". The ADHINCRA Program is a bundle of multilevel evidence-based interventions that address multiple predictors of controlled hypertension, including patient-, provider-, and health system-level factors. The successful implementation of the ADHINCRA program will provide a rigorous and scalable model fo...
What is the current status of trial NCT06986590?
This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2026-01-09. Estimated completion is 2028-09.
What conditions does trial NCT06986590 study?
This clinical trial studies the following conditions: Hypertension, High Blood Pressure. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT06986590?
The interventions under investigation include: ADHINCRA Program (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT06986590?
This trial is sponsored by Johns Hopkins University, which has 1,517 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT06986590 being conducted?
This trial has 17 study locations across Maryland, Ashanti Region, Bono, Northern Region, Volta Region. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.